Skip to main content
Premium Trial:

Request an Annual Quote

Transgenomic Lab Accredited By College of American Pathologists

NEW YORK (GenomeWeb News) – Transgenomic announced today that the College of American Pathologists’ Commission on Laboratory Accreditation has awarded its laboratory an accreditation following a recent on-site inspection, making Transgenomic one of more than 6,000 CAP-accredited American labs.
 
CAP started its Laboratory Accreditation Program nearly half a century ago. It is reportedly regarded by the federal government as being as or more stringent than the government inspection program. The program involves evaluation of laboratory records, quality control procedures, staff qualifications, management, and laboratory equipment, facilities, and safety records.
 
Transgenomic CEO Craig Tuttle called the accreditation a validation of the company’s laboratory services. “We plan to immediately pursue the benefits of the accreditation in our pursuit of projects and revenue growth,” he said in a statement. “We are confident that CAP accreditation will put Transgenomic on the map as a laboratory with the highest standard in molecular diagnostics.”
 
Transgenomic offers products and services for evaluating genetic variation and mutation analysis.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.